<DOC>
	<DOC>NCT02049307</DOC>
	<brief_summary>The purpose of this study is to evaluate the potential effectiveness of losartan (100mg daily) for reducing inflammation and improving immune recovery.</brief_summary>
	<brief_title>Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>HIV infection (verified by previous positive antibody or detectable HIV RNA level) Age &gt; 50 years Receiving continuous ART for &gt;= 2 years (regimen changes &gt; 6 months prior to enrollment are allowed) HIV RNA level &lt; 200 copies/mL for &gt;= 1 year (1 measure &gt;= 200 allowed if also &lt; 1000 and preceded and followed by values &lt; 200 copies/mL) Blood CD4+ Tcell count &lt; 600 cells/mm cubed Systolic blood pressure &gt; 120 mmHg (mean value if &gt;= 2 measures obtained) Estimated glomerular filtration rate (GFR )&gt; 30 mL/min/1.73 m squared Do not anticipate starting or stopping statin or aspirin therapy during the study Pregnancy or breastfeeding A contraindication to taking an angiotensin receptor blocker (ARB) (e.g., cirrhosis, prior angioedema with angiotensinconverting enzyme inhibitor (ACEI), or use of drug with potential druginteraction [e.g., rifaximin]) A clinical indication for ARB or ACEI therapy (e.g., cardiovascular disease (CVD), stroke, or diabetes mellitus (DM)) Current treatment with ARB or medication with overlapping mechanism (e.g., ACEI or aldosterone antagonist) Current treatment with immunomodulatory drugs within the past 6 months Current hepatitis treatments (e.g., interferon, ribavirin) within the past 6 months Serum potassium &gt; 5.0 millimoles per liter (mmol/L) within 3 months of entry Invasive cancer in the prior year or receiving cancer treatment (not including carcinomainsitu or basal cell cancer of the skin) Cirrhosis or endstage liver disease Rheumatologic or chronic inflammatory disease (e.g., systematic lupus erythematous, psoriasis, rheumatoid arthritis, vasculitis, sarcoidosis, Crohn's disease)</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>